Informuta’s mission is to revolutionize infectious disease detection and enable precision medicine for infections.
We do this through artificial intelligence/machine learning (AI/ML)-powered analytics of DNA, namely next-generation sequencing (NGS), data.
Our novel, proprietary technology allows us to leverage DNA sequencing to predict if bacteria will respond to different antibiotics or develop resistance to them over time.
Our vision is to address the global health crisis of antibiotic resistance and save lives by learning to better use and therefore conserve our current market-approved antibiotics.
Kalen pioneered Informuta’s technology that predicts future resistance acquisition during her PhD work at Tulane University School of Medicine. Driven by a lifelong passion for scientific discovery, Kalen's research career began in high school and continued through her Biochemistry and Anthropology degrees at the University of Florida, wh
Kalen pioneered Informuta’s technology that predicts future resistance acquisition during her PhD work at Tulane University School of Medicine. Driven by a lifelong passion for scientific discovery, Kalen's research career began in high school and continued through her Biochemistry and Anthropology degrees at the University of Florida, where she did her honors thesis and graduated Magna Cum Laude. During her PhD at Tulane, Kalen began diving into the world of entrepreneurship, and she is dedicated to bringing her scientific innovations to market to improve patient outcomes. Kalen has actively honed her business acumen through programs like the NSF I-Corps, Tulane Innovation Institute Mentorship Program, and the Equalize Program, blending rigorous scientific methodology with strategic business insights to lead Informuta effectively.
ResearchGate: https://www.researchgate.net/profile/Kalen-Hall-2
LinkedIn:
Leo is a recent PhD graduate from Tulane’s Bioinnovation Program, where his research focused on mutagenesis and tumorigenesis in human cancers, particularly those related to POLE and BRCA1 mutations. From a young age, Leo was captivated by science and technology, with a lifelong aspiration to create innovations that significantly improve
Leo is a recent PhD graduate from Tulane’s Bioinnovation Program, where his research focused on mutagenesis and tumorigenesis in human cancers, particularly those related to POLE and BRCA1 mutations. From a young age, Leo was captivated by science and technology, with a lifelong aspiration to create innovations that significantly improve lives. His academic journey led him from a B.S. in Biochemistry at Louisiana State University to Tulane, where he was pivotal in applying next-generation DNA sequencing to tumor genomes. Leo’s knack for bioinformatics emerged when he taught himself coding to tackle data analysis challenges, subsequently mastering computational, statistical, and machine learning methods to decode genomic data and engineer software for reproducibility and communication. His expertise extends to medical device regulation, having interned at the FDA, ensuring a well-rounded leadership in transitioning scientific discoveries to market-ready technologies.
ResearchGate: https://www.researchgate.net/scientific-contributions/Leonard-G-Williams-2175839060
LinkedIn:
Justen is a recent graduate of Tulane University’s MBA program with concentrations in finance and business analytics and will build budgeting, forecasting, and valuation models. His bachelor’s in Integrative Physiology and clinical experience give him an understanding of the importance of Informuta’s mission.
Demi is a dedicated research professional who has completed a Master of Science in Biology and undergraduate studies in Biochemistry and Cell Biology. With extensive experience in advanced scientific techniques and laboratory management, Demi has made significant contributions to the development and analysis of complex DNA constructs, uti
Demi is a dedicated research professional who has completed a Master of Science in Biology and undergraduate studies in Biochemistry and Cell Biology. With extensive experience in advanced scientific techniques and laboratory management, Demi has made significant contributions to the development and analysis of complex DNA constructs, utilizing expertise in cloning methods, next-generation DNA sequencing, and quality control. Her work includes optimizing production processes and improving team efficiency in dynamic biotech environments. Demi’s background also includes substantial experience in studying and analyzing microbiome dynamics, reflecting her commitment to advancing our understanding of microbial influences on health and disease.
Linkedin: https://www.linkedin.com/in/demi-v-flores-126820149
Brandon is currently pursuing a dual major in Computer Science and Economics, with a minor in Strategy, Leadership, and Analytics (SLAM) at Tulane University. He is in the class of 2026. Brandon has experience in the following programming languages: Java, Python, C, C++, SQL, PHP, HTML, and CSS. Originally from Philadelphia, Pennsylvania, he enjoys playing golf and ice hockey.
Sara is a Finance major and Real Estate minor at Tulane University, set to graduate in 2027. With a keen interest in business and a specific focus on investment banking, she brings her analytical skills and industry knowledge to her role. Her academic background and passion for finance enable her to contribute to the strategic positioning and market presence of her projects.
Associate Professor of Biochemistry & Molecular Biology, Tulane University School of Medicine
ResearchGate: https://www.researchgate.net/profile/Zachary-Pursell-2
Professor of Microbiology, Tulane University School of Medicine
ResearchGate: https://www.researchgate.net/scientific-contributions/Lisa-A-Morici-16092533
COO & Founder, Cadenzo Bio
CEO, CLAIRIgene
CEO & Founder, Ascend BioVentures
President, Otologic Pharmaceutics
COO & Founder, Kirrhos Pharmaceuticals
COO, Accele Biopharma, Inc.
Venture Advisor & Director of Venture Assessment, i2E, Inc.
Pediatric Infectious Diseases Physician, Boston Children’s Hospital
VP Medical Innovation, Karius
ResearchGate: https://www.researchgate.net/profile/Asim-Ahmed-7
Cofounder, Atzeyo Biosensors, Inc.
Chief Marketing Officer, Chief Operating Officer, Applied Silver, Inc.
Advisor, mFluiDx & Sandstone Diagnostics, Inc.
Associate Director of Global Product Management, Thermo Fisher Scientific
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.